The fact that RIF1 does not appear to alter its splicing pattern in basal breast cancer is surprising, particularly in comparison to its behaviour in LumA, LumB, and HER2E cancer subtypes, where it behaves as a ‘typical’ Cancer-Altered Short exon in its tendency to show increased exclusion in these receptor-positive cancers. Here, RIF1 is linked to cancer.